Clinical trial Recruiting at 3 sites Phase 3 Interventional Ages 60 and up

Sleep, Cognition, and Pain Bundle versus ERAS‑cardiac to Prevent Delirium After Heart Surgery

Official title: The SCOPE Trial: Sleep, Cognition, and Pain Bundle vs. ERAS-cardiac for Postoperative Delirium

Run by Beth Israel Deaconess Medical Center · NCT06721819 · Data updated 2026-11-12

This trial will try a package of sleep improvement, pre-surgery brain exercises on a tablet, and 48 hours of IV acetaminophen alongside standard ERAS care to see if it lowers delirium in people 60 and older having planned heart surgery.

More Delirium - Postoperative trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages60 Years and up
SexAll
Enrollment406 (estimated)
SponsorBeth Israel Deaconess Medical Center
Academic / other
Locations3 sites (Boston, Massachusetts and 2 other locations)
StatusRecruiting
StartedJune 6, 2025
Main results expectedJune 30, 2029
Study endsMarch 31, 2030
Registry record updatedApril 15, 2026
Trial IDNCT06721819 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking adults aged 60 or older with planned CABG or valve surgery via median sternotomy with cardiopulmonary bypass at least 10 days away who can use a provided tablet and wearable and commit roughly one hour per day preoperatively.

Probably not a fit

Patients less likely to benefit include those with preoperative delirium, LVEF under 30%, emergent or isolated aortic surgery, significant liver dysfunction, recent alcohol abuse, known hypersensitivity to study drugs, or inability to use the tablet or understand English.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The SCOPE trial compares a multicomponent intervention—pre- and post-operative sleep optimization, preoperative cognitive exercises delivered via provided tablets and wearables, and 48 hours of IV acetaminophen for opioid-sparing pain control—added to standard ERAS‑cardiac versus ERAS protocols alone. Eligible participants are adults aged 60 or older scheduled for planned median sternotomy cardiac surgery (CABG with or without valve, or isolated valve surgery) with cardiopulmonary bypass, recruited at major academic centers. The study tracks postoperative delirium incidence and duration as primary outcomes and follows secondary outcomes including cognitive and physical function, sleep quality, pain, mood, and survival. Participants randomized to the intervention are asked to use the provided devices and commit about one hour per day before surgery to the cognitive and behavioral components.

Why it matters

Potential benefit: If successful, the bundle could reduce how often and how long patients experience postoperative delirium and improve recovery, cognition, sleep, pain control, and mood after heart surgery.

How similar studies have gone: Individual elements like sleep hygiene, cognitive prehabilitation, and multimodal opioid-sparing analgesia have shown benefit in other settings, but the combined SCOPE bundle specifically for preventing delirium after cardiac surgery is novel and not yet proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Planned cardiac surgery \[CABG with or without valve, isolated valve surgery\] requiring median sternotomy and full CPB at least 10 days in the future.

  * 60 years of age.

Willingness to use a provided tablet and wearable devices and commit at least 1 hour amount of time per day before surgery to complete interventions (psCBT/cognitive activity/exercise) if randomized to experimental group.

Exclusion Criteria:

* Pre-operative left ventricular ejection fraction (LVEF) \< than 30%

Emergent procedures

Isolated aortic surgery

Liver dysfunction (ALT or AST \> 4 times the upper limit of local normal; all patients will have a baseline liver function test information or history and exam suggestive of jaundice or both)

Known hypersensitivity to the study drugs

Active (in the past year) history of alcohol abuse (≥ 5 drinks/day for men or ≥ 4 drinks/day for women) Any history of alcohol withdrawal or delirium tremens

Delirium at baseline

English language Limitations

Physician refusal

Chronic opioid use for chronic pain conditions with tolerance (total dose of an opioid at or more than 30 mg morphine equivalent for more than one month within the past year)

Significant visual impairment

Prisoner

Severe OSA in the past year (AHI is greater than 30 (more than 30 episodes per hour)) or ESS of 18 or more

Co-enrollment with non-approved interventional trial

Severe cognitive impairment (MOCA \< 10) or medications for cognitive decline

Recent treatment for insomnia with CBT-I within the last 6 months

Where it's running

  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting
  • Columbia University Irving Medical Center
    New York, New York, United States
    Recruiting
  • The Ohio State University
    Columbus, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.